Petukhov et al. previously demonstrated that CAR-T cells dramatically reduce (down to 9.3%) the confluence of myelogenous leukemia (K562) cells transduced with the CD19 antigen [7]. This evidence concerns the gene CD19 and myeloid leukemia.